Back to search results

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Oropharyngeal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Jesse Zaretsky, M.D.) · jzaretsky@wustl.edu · 314-747-8244
    Contact: Principal Investigator (Jesse Zaretsky, M.D.)
    Sidharth Puram, M.D., Ph.D. (Sub-investigator)
    Peter Oppelt, M.D. (Sub-investigator)
    Ryan Jackson, M.D. (Sub-investigator)
    Jason Rich, M.D. (Sub-investigator)
    Randal Paniello, M.D. (Sub-investigator)
    Patrik Pipkorn, M.D. (Sub-investigator)
    Christine Auberle, M.D. (Sub-investigator)
    Esther Lu, Ph.D. (Sub-investigator)
    Wade Thorstad, M.D. (Sub-investigator)
    R. Alex Harbison, M.D., MS (Sub-investigator)
    Paul Zolkind, M.D. (Sub-investigator)
    Kathryn Schwetye, M.D., Ph.D. (Sub-investigator)
    Anthony Apicelli, M.D., Ph.D. (Sub-investigator)
    Jennifer De Los Santos, M.D. (Sub-investigator)
    Brendan Knapp, M.D. (Sub-investigator)
    Nikhil Rammohan, M.D., Ph.D. (Sub-investigator)
    Douglas Adkins, M.D. (Sub-investigator)
    Ben Wahle, M.D. (Sub-investigator)
    Daniel Miller, M.D., Ph.D. (Sub-investigator)
Study leads

  • Jesse Zaretsky, M.D.

    Principal Investigator

    Washington University School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)